MyFinsight
Home
Blog
About
REPLIGEN CORP (RGEN)
REPLIGEN CORP (RGEN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$24,166K
Free Cash flow
$27,432K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Depreciation and amortization
Accrued liabilities
Others
Negative Cash Flow Breakdown
Cost of goods sold
Purchases of marketable securiti...
General and administrative
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
204,128
194,255
197,913
540,343
Cost of goods sold
94,889
86,432
94,082
257,929
Research and development
15,086
14,756
13,120
41,057
Sales and marketing
28,218
28,214
27,825
77,495
General and administrative
51,959
48,913
45,018
126,563
Total costs and operating expenses
190,152
178,315
180,045
503,044
Other income (expense), net
177
-14,168
1,245
5,971
Income tax provision
9,145
-6,561
5,826
7,663
Net income
5,008
8,333
13,287
14,911
Depreciation and amortization
19,062
19,762
19,951
20,009
Amortization of debt discount and issuance costs
4,461
4,372
4,286
12,360
Inventory step-up amortization
-
-
491
1,069
Loss on sale of business
103
-13,763
-
-
Stock-based compensation
8,013
8,322
7,984
8,973
Deferred income taxes, net
2,925
-7,700
2,411
-3,215
Change in fair value of contingent consideration
2,308
-146
-1,520
-4,148
Non-cash interest income
-
-
0
-
Loss on extinguishment of debt
-
-
0
-
Net unrealized foreign exchange gain
157
-38
571
190
Operating lease right of use asset amortization
4,711
4,775
4,641
13,570
Other adjustments and non-cash items
488
1,327
902
-2,179
Accounts receivable
7,548
-3,186
9,863
-7,856
Inventories
8,089
12,069
9,601
4,522
Prepaid expenses and other current assets
3,984
1,978
2,262
5,318
Other noncurrent assets
-1,868
-26
-167
180
Accounts payable
194
5,918
933
3,194
Accrued liabilities
12,128
-12,655
2,184
12,624
Operating lease liabilities
-7,764
-5,594
-3,460
-2,292
Noncurrent liabilities
221
1,269
-2,452
637
Total cash provided by operating activities
32,766
28,295
25,704
48,099
Acquisitions, net of cash acquired
0
0
374
0
Divestiture proceeds, net of cash divested
3,637
-
-
-
Purchases of marketable securities
66,073
64,625
200,257
-
Maturities of marketable securities
66,000
66,000
0
-
Additions to capitalized software costs
735
237
156
684
Purchases of property, plant and equipment
5,334
4,710
8,153
4,702
Sale of property, plant and equipment
0
0
196
0
Purchase of intellectual property
-
-
0
-
Other investing activities
-
416
0
2,397
Total cash used in investing activities
-2,089
-3,988
-208,744
-7,783
Repurchase of common stock
-
-
0
-
Proceeds from issuance of 2023 notes
-
-
0
-
Proceeds from exercise of stock options
94
0
1,034
678
Payment of debt issuance costs
-
-
0
-
Payment of tax withholding obligation on vesting of restricted stock
1,069
5,543
839
824
Repayment of 2019 notes
-
-
0
0
Payment of earnout consideration
5,225
-
0
93
Other financing activities
-
-
0
-
Total cash used in financing activities
-6,200
-5,543
195
-239
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-311
-145
119
-185
Net increase (decrease) in cash, cash equivalents and restricted cash
24,166
18,619
-182,726
39,892
Cash, cash equivalents and restricted cash, beginning of period
584,640
566,021
748,747
757,355
Cash, cash equivalents and restricted cash, end of period
608,806
584,640
566,021
748,747
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Revenue
$204,128K
Other income
(expense), net
$177K
Depreciation and
amortization
$19,062K
(-50.85%↓ Y/Y)
Accrued liabilities
$12,128K
(504.94%↑ Y/Y)
Stock-based compensation
$8,013K
(-48.79%↓ Y/Y)
Net income
$5,008K
(-75.80%↓ Y/Y)
Operating lease right of
use asset...
$4,711K
(151.38%↑ Y/Y)
Amortization of debt discount
and issuance costs
$4,461K
(-45.32%↓ Y/Y)
Deferred income taxes,
net
$2,925K
(213.86%↑ Y/Y)
Change in fair value of
contingent consideration
$2,308K
(129.07%↑ Y/Y)
Other noncurrent
assets
-$1,868K
(-220.75%↓ Y/Y)
Noncurrent liabilities
$221K
(-13.67%↓ Y/Y)
Accounts payable
$194K
(102.34%↑ Y/Y)
Canceled cashflow
$199,297K
Total cash provided by
operating activities
$32,766K
(-24.87%↓ Y/Y)
Canceled cashflow
$28,133K
Total costs and
operating expenses
$190,152K
Income tax provision
$9,145K
Net increase
(decrease) in cash, cash...
$24,166K
(149.83%↑ Y/Y)
Canceled cashflow
$8,600K
Inventories
$8,089K
(881.67%↑ Y/Y)
Operating lease
liabilities
-$7,764K
(20.81%↑ Y/Y)
Accounts receivable
$7,548K
(-50.20%↓ Y/Y)
Prepaid expenses and
other current assets
$3,984K
(2163.64%↑ Y/Y)
Other adjustments and
non-cash items
$488K
(238.24%↑ Y/Y)
Net unrealized
foreign exchange gain
$157K
(-98.72%↓ Y/Y)
Loss on sale of
business
$103K
Proceeds from exercise of
stock options
$94K
(-93.58%↓ Y/Y)
Maturities of marketable
securities
$66,000K
Divestiture proceeds, net of
cash divested
$3,637K
something is missing
$416K
Cost of goods sold
$94,889K
General and
administrative
$51,959K
Sales and marketing
$28,218K
Research and development
$15,086K
Total cash used in
financing activities
-$6,200K
(59.11%↑ Y/Y)
Total cash used in
investing activities
-$2,089K
(97.45%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$311K
(-106.23%↓ Y/Y)
Canceled cashflow
$94K
Canceled cashflow
$70,053K
Payment of earnout
consideration
$5,225K
(-44.74%↓ Y/Y)
Payment of tax
withholding obligation on...
$1,069K
(-85.09%↓ Y/Y)
Purchases of marketable
securities
$66,073K
Purchases of property,
plant and equipment
$5,334K
(-49.98%↓ Y/Y)
Additions to capitalized
software costs
$735K
(-46.39%↓ Y/Y)
Buy us a coffee